phenol has been researched along with Epithelial Ovarian Cancer in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Upon treatment with oleuropein, the expression of P21, P53, and TNFRSF10B increased while that of Bcl-2 and Mcl1 decreased." | 1.62 | Oleuropein reduces cisplatin resistance in ovarian cancer by targeting apoptotic pathway regulators. ( Amini-Farsani, Z; Asgharzade, S; Hashemi Sheikhshabani, S; Jazaeri, A; Mohammadi-Samani, M; Rahmati, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashemi Sheikhshabani, S | 1 |
| Amini-Farsani, Z | 1 |
| Rahmati, S | 1 |
| Jazaeri, A | 1 |
| Mohammadi-Samani, M | 1 |
| Asgharzade, S | 1 |
1 other study available for phenol and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Oleuropein reduces cisplatin resistance in ovarian cancer by targeting apoptotic pathway regulators.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferatio | 2021 |